| scholarly article | Q13442814 |
| P50 | author | Eishun Tsuchida | Q105771981 |
| P2093 | author name string | Yasuo Ikeda | |
| Hideki Narumi | |||
| Hiromi Tsuchiyama | |||
| Makoto Handa | |||
| Mie Kainoh | |||
| Shinji Takeoka | |||
| Yosuke Okamura | |||
| Yuji Teramura | |||
| P2860 | cites work | Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen | Q28364081 |
| Targeting of liposomes carrying recombinant fragments of platelet membrane glycoprotein Ibalpha to immobilized von Willebrand factor under flow conditions | Q30860031 | ||
| Rhodocytin induces platelet aggregation by interacting with glycoprotein Ia/IIa (GPIa/IIa, Integrin alpha 2beta 1). Involvement of GPIa/IIa-associated src and protein tyrosine phosphorylation | Q31473281 | ||
| Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex | Q31974821 | ||
| Novel platelet products, substitutes and alternatives | Q33338494 | ||
| Fibrinogen-conjugated albumin polymers and their interaction with platelets under flow conditions | Q33340486 | ||
| Production of soluble integrin alpha2beta1 heterodimer complex functionally active in vitro and in vivo | Q33340506 | ||
| Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia | Q33365111 | ||
| A liposome based platelet substitute, the plateletsome, with hemostatic efficacy | Q33493616 | ||
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Q33501152 | ||
| Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits | Q33504864 | ||
| The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress | Q34182746 | ||
| Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions | Q35597837 | ||
| Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field | Q36407260 | ||
| Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions | Q44053756 | ||
| Rolling properties of rGPIbalpha-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions | Q44100697 | ||
| Conjugation of von Willebrand factor-binding domain of platelet glycoprotein Ib alpha to size-controlled albumin microspheres | Q47198865 | ||
| Glycoprotein Ia/IIa-mediated activation-dependent platelet adhesion to collagen | Q68115830 | ||
| Improving the quality of stored platelets | Q68180782 | ||
| Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions: specific synergy of receptor-ligand interactions | Q74314265 | ||
| Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion | Q78109621 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombocytopenia | Q585285 |
| P304 | page(s) | 256-260 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Hemostatic effects of polymerized albumin particles bearing rGPIa/IIa in thrombocytopenic mice | |
| P478 | volume | 306 |
| Q90697102 | Engineering blood cells and proteins as blood substitutes: A short review |
| Q33373596 | New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions |
| Q33375630 | Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide |
| Q34706866 | Surgical Materials: Current Challenges and Nano-enabled Solutions. |
| Q35858739 | Synthetic Strategies for Engineering Intravenous Hemostats |
| Q36647460 | Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others |
Search more.